oral contraceptives

DRUG2 trials

Sponsors

FHI 360, pharmaand GmbH

Conditions

ContraceptionNeoplasms

Phase 1

Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptives

CompletedNCT03954366

pharmaand GmbHNeoplasms

Start: 2019-04-25End: 2021-06-09Updated: 2023-06-08

Phase 4

Long-Acting Reversible Contraception

CompletedNCT01299116

FHI 360Contraception

Start: 2011-12-31End: 2016-12-31Updated: 2018-02-28

Related Papers

A phase 1, open-label, drug-drug interaction study of rucaparib with rosuvastatin and oral contraceptives in patients with advanced solid tumors.

2021-08-098 citations